Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: Primary clinical results of the ACADEMIC study

被引：0
|
作者：
Muhlestein, JB [1 ]
Anderson, JL [1 ]
Carlquist, JF [1 ]
Horne, BD [1 ]
Pearson, RR [1 ]
Bair, TL [1 ]
Bunch, TJ [1 ]
Salunkhe, K [1 ]
Maycock, CA [1 ]
Kim, SK [1 ]
机构：
[1] Univ Utah, Latter Day St Hosp, Salt Lake City, UT 84143 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2000年 / 35卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：274A / 274A
页数：1
相关论文
共 50 条
  • [1] Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC Study
    Muhlestein, J
    Anderson, J
    Carlquist, J
    Salunkhe, K
    Horne, B
    Pearson, R
    Bunch, T
    Allen, A
    Trehan, S
    Nielson, C
    JOURNAL OF VASCULAR SURGERY, 2001, 33 (05) : 1137 - 1137
  • [2] Randomized secondary prevention trial of azithromycin in patients with coronary artery disease - Primary clinical results of the ACADEMIC study
    Muhlestein, JB
    Anderson, JL
    Carlquist, JF
    Salunkhe, K
    Horne, BD
    Pearson, RR
    Bunch, TJ
    Allen, A
    Trehan, S
    Nielson, C
    CIRCULATION, 2000, 102 (15) : 1755 - 1760
  • [3] Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection -: The azithromycin in coronary artery disease:: Elimination of myocardial infection with Chlamydia (ACADEMIC) study
    Anderson, JL
    Muhlestein, JB
    Carlquist, J
    Allen, A
    Trehan, S
    Nielson, C
    Hall, S
    Brady, J
    Egger, M
    Horne, B
    Lim, T
    CIRCULATION, 1999, 99 (12) : 1540 - 1547
  • [4] Azithromycin for the secondary prevention of coronary heart disease events - The WIZARD study: A randomized controlled trial
    O'Connor, CM
    Dunne, MW
    Pfeffer, MA
    Muhlestein, JB
    Yao, L
    Gupta, S
    Benner, RJ
    Fisher, MR
    Cook, TD
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (11): : 1459 - 1466
  • [5] Impact of pravastatin on secondary prevention of coronary artery disease in normolipidemic patients: Prospective randomized trial (PCS study)
    Kirino, M
    Sato, S
    Kobayashi, T
    Nakagawa, Y
    Hiraoka, H
    Katoh, O
    Shibata, N
    Awata, N
    Kobayashi, T
    Reiber, JHC
    Zwinderman, AH
    CIRCULATION, 1998, 98 (17) : 534 - 534
  • [6] The primary and secondary prevention of coronary artery disease
    Becker, Richard C.
    Meade, Thomas W.
    Berger, Peter B.
    Ezekowitz, Michael
    O'Connor, Christopher M.
    Vorchheimer, David A.
    Guyatt, Gordon H.
    Mark, Daniel B.
    Harrington, Robert A.
    CHEST, 2008, 133 (06) : 776S - 814S
  • [7] Efficacy of participatory education as compared to clinical guidelines in secondary prevention of patients with coronary artery disease: A randomized study
    Kiessling, A
    Henriksson, P
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 435A - 435A
  • [8] Azithromycin for the secondary prevention of coronary artery disease: A meta-analysis
    Baker, William L.
    Couch, Kimberly A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (08) : 830 - 836
  • [9] The Enhancing Secondary Prevention in Coronary Artery Disease trial
    McAlister, Finlay A.
    Fradette, Miriam
    Majumdar, Sumit R.
    Williams, Randall
    Graham, Michelle
    McMeekin, James
    Ghali, William A.
    Tsuyuki, Ross T.
    Knudtson, Merril L.
    Grimshaw, Jeremy
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2009, 181 (12) : 897 - 904
  • [10] PRIMARY AND SECONDARY PREVENTION OF CORONARY-ARTERY DISEASE
    GOTTO, AM
    CURRENT OPINION IN CARDIOLOGY, 1992, 7 (04) : 553 - 562
12345